Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 564-571

  Dupont, Isabelle ^c   Lucas, Daniele ^c   Clot, Paolo ^a   Ménez, Catherine ^b   Albano, Emanuele ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b BREST UNIVERSITY HOSPITAL   (France)

^c NONE

Author keywords

Alcohol; Cytochrome P450 2E1; Free radicals; Immunological response; Oxidative damages

Indexed keywords

ALCOHOL; CHLORZOXAZONE; CYTOCHROME P450; FREE RADICAL; IMMUNOGLOBULIN G;

AEROBIC METABOLISM; ALCOHOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIPID PEROXIDATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MICROSOME; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0031961095     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80279-1     Document Type: Article

References (36)

1. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology. 106:1994;1085-1105.
2. Ingelman-Sundberg M, Johansson I, Eliasson E, Ekström G, Bühler R, Lindros K. Ethanol-inducible cytochrome P4502E1: toxicological importance and regulation by nutrients. Parke DV, Ioannides C, Walker R. Food, Nutrition and Chemical Toxicity. 1993;147-159 Smith-Gordon, London.
3. Ekström G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450. Biochem Pharmacol. 38:1989;1313-1318.
4. Ekström G, Von Bahr C, Ingelman-Sundberg M. Human liver cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. Biochem Pharmacol. 38:1989;689-693.
5. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact. 65:1988;223-234.
6. Knecht KT, Bradfort BU, Mason RP, Thurman RG. In vivo formation of free radical metabolite of ethanol. Mol Pharmacol. 38:1990;26-30.
7. Albano E, Tomasi A, Goria-Gatti L, Persson JO, Terelius Y, Ingelman-Sundberg M, et al. Role of ethanol-inducible cytochrome P-450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol. 41:1991;1895-1902.
8. Morimoto M, Hagbjörk A-L, Wan YJY, Fu PC, Ingelman-Sundberg M, Albano E, et al. Modulation of alcoholic liver disease by cytochrome P4502E1 inhibitors. Hepatology. 211:1995;610-617.
9. Albano E, Clot P, Morimoto M, Tomasi, Ingelman-Sundberg M, French S. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radicals in the development of liver damage in rats intragastrically fed with ethanol. Hepatology. 23:1996;155-163.
10. Clot P, Bellomo G, Tabone M, Aricò S, Albano E. Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology. 108:1995;201-207.
11. Clot P, Albano E, Elliasson E, Tabone M, Aricò S, Israel Y, et al. Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigenic determinant for autoantibody formation among alcoholics. Gastroenterology. 111:1995;206-216.
12. Peter R, Bocker R, Beaune Ph, Iwasaki M, Guengerich FP. Hydroxylation of chlorzoxazone as a specific probe for human liver CYP2E1. Chem Res Toxicol. 3:1990;566-573.
13. Lucas D, Ménez JF, Berthou F. Chlorozazone: an in vivo and in vitro substrate probe for liver CYP2E1. Meth Enzymol. 272:1996;115-123.
14. Kim RB, O'Shea D, Wilkinson GR. Relationship in healthy subjects between CYP2E1 genetic polymorphism and the 6-hydroxylation of chrozoxazone: a putative measure of CYP2E1 activity. Pharmacogenet. 4:1994;162-165.
15. Girre C, Lucas D, Hispard E, Ménez C, Dally S, Ménez JF. Assessment of cytochrome P4502E1 induction in alcoholic patients by chorzoxazone pharmacokinetics. Biochem Pharmacol. 47:1994;1503-1508.
16. Lucas D, Ménez C, Girre C, Bodenez P, Hispard E, Ménez JF. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Alcohol Clin Exp Res. 19:1995;362-366.
17. Guengerich FP, Turvy CG. Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther. 256:1991;1189-1194.
18. Lucas D, Berthou F, Dréano Y, Lozac'h P, Volant A, Ménez JF. Comparison of the levels of cytochrome P450, CYP1A2, CYP2E1, and their related monoxygenase activities in human liver surgical samples. Alcohol Clin Exp Res. 17:1993;900-905.
19. Lucas D, Berthou F, Girre C, Poitrenaud F, Ménez JF. High-performance liquid chromatographic determination chlorzoxazone and 6-hydroxychlorzoxazone is serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr (Biomed Appl). 622:1993;79-86.
20. Lucas D, Ménez C, Girre C, Berthou F, Bodénez P, Joannet I, Hispard E, et al. Cytochrome P4502E1 genotype and chorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenet. 5:1995;298-304.
21. Comiacini M, Garbin U, Davoli A, Micciolo R, Bosello O, Gaviraghi G, et al. A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalysed oxidative modification. J Lipid Res. 32:1991;349-358.
22. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, et al. Both cytochrome P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol. 6:1993;852-857.
23. Lecomte E, Herberth B, Pirrolet P, Chancerelle Y, Arnaud J, Musse N, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr. 60:1994;255-261.
24. Nedelcheva V, Persson I, Ingelman-Sundberg M. Genetic polymorphisms of human cytochrome P450 2E1. Meth Enzymol. 272:1996;218-225.
25. Hayashi S-I, Watanabe J, Kawajiri K. Genetic polymorphisms in 5′-flanking region change transcriptional regulation of the human CYP2E1 gene. J Biochem. 110:1991;559-565.
26. Savolainen VT, Pajarinen J, Perola M, Penttilä A, Karhunen PJ. Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease. J Hepatol. 26:1997;55-61.
27. Hirvonen A, Husgafvel-Pursiainen K, Antilla S, Karjailainen A, Vainio H. The human CYP2E1 gene and lung cancer: Dra I and Rsa I restriction fragment length polymorphisms in a Finnish population. Carcinogenesis. 14:1993;85-88.
28. Lucas D, Ménez C, Floch F, Gourlaouen Y, Sparfel O, Joannet I, et al. Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholics. Alcohol Clin Exp Res. 20:1996;1033-1037.
29. Hu Y, Oscarson M, Johansson I, Yue YQ, Dahl AI, Tabone M, et al. Genetic polymorphism of human CYP2E1. Characterisation of two variant alleles. Mol Pharmacol. 51:1997;370-376.
30. Albano E, Tomasi A, Ingelman-Sundberg M. Spin trapping of alcohol-derived radicals in microsomes and reconstituted systems by electron spin resonance. Meth Enzymol. 233:1994;117-127.
31. Nordmann R, Ribière C, Rouach H. Implication of free radical mechanisms in ethanol induced cellular injury. Free Rad Biol Med. 12:1992;219-240.
32. Lettèron P, Duchatelle V, Berson A, Fromenty B, Degott C, Benhamou JP, Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut. 34:1993;409-414.
33. Clot P, Tabone M, Aricò S, Albano E. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake. Gut. 35:1994;1637-1643.
34. Clot P, Parola M, Bellomo G, Dianzani U, Tabone M, Aricò S, et al. Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcohol. Gastroenterology. 113:1997;265-276.
35. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology. 17:1993;9-13.
36. Klassen LW, Tuma D, Sorrell MF. Immune mechanisms of alcohol-induced liver disease. Hepatology. 22:1995;355-357.